The Food and Drug Administration announced on Monday that it has granted emergency authorization of Eli Lilly's COVID-19 treatment for use in certain cases.
The treatment is called bamlanivimab, and it has been approved for use in people who have tested positive for the coronavirus, are 12 and older, and at risk for developing a severe form of COVID-19 or being hospitalized, The New York Times reports. This includes people who are 65 or older and obese, as early studies have shown they can benefit the most from this treatment. It should be administered to a person as soon as possible after they test positive, and within 10 days of developing systems.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Passenger jet, Blackhawk helicopter collide in DCSpeed Read An American Airlines flight with 64 people aboard collided with an Army helicopter, and no survivors have been found
-
White House withdraws Trump's spending freezeSpeed Read President Donald Trump's budget office has rescinded a directive that froze trillions of dollars in federal aid and sowed bipartisan chaos
-
Washington DC plane crash: how did mid-air collision happen?Today's Big Question Experts struggle to explain how sophisticated airspace control system failed to prevent deadly disaster
-
Chinese AI chatbot's rise slams US tech stocksSpeed Read The sudden popularity of a new AI chatbot from Chinese startup DeepSeek has sent U.S. tech stocks tumbling
-
US port strike averted with tentative labor dealSpeed Read The strike could have shut down major ports from Texas to Maine
-
Biden expected to block Japanese bid for US SteelSpeed Read The president is blocking the $14 billion acquisition of U.S. Steel by Japan's Nippon Steel, citing national security concerns
-
Judges block $25B Kroger-Albertsons mergerSpeed Read The proposed merger between the supermarket giants was stalled when judges overseeing two separate cases blocked the deal
-
Rupert Murdoch loses 'Succession' court battleSpeed Read Murdoch wanted to give full control of his empire to son Lachlan, ensuring Fox News' right-wing editorial slant
-
Bitcoin surges above $100k in post-election rallySpeed Read Investors are betting that the incoming Trump administration will embrace crypto
-
Enron mystery: 'sick joke' or serious revival?Speed Read 23 years after its bankruptcy filing, the Texas energy firm has announced its resurrection
-
US charges Indian tycoon with bribery, fraudSpeed Read Indian billionaire Gautam Adani has been indicted by US prosecutors for his role in a $265 million scheme to secure solar energy deals
